Literature DB >> 20349521

Relationships between serum lipid, lipoprotein, triglyceride-rich lipoprotein, and high-density lipoprotein particle concentrations in post-renal transplant patients.

Elzbieta Kimak1, Magdalena Hałabiś, Iwona Baranowicz-Gaszczyk.   

Abstract

OBJECTIVE: Disturbances in lipid and lipoprotein profiles in patients after kidney transplantation (Tx) are still not understood.
METHODS: Serum levels of lipids, lipoprotein, triglyceride-rich lipoproteins (TRLs), and high-density lipoprotein (HDL) particles were determined, lipid and lipoprotein ratios were calculated, and their relationships in Tx patients with hypertriglyceridemia (HTG) and lower apolipoprotein AI (apoAI) concentration were examined. Serum lipid and lipoprotein levels were measured in 109 Tx patients and 89 healthy subjects. HDL particle levels were determined by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Tx patients had disturbed concentration, composition, and metabolism of TRLs and HDL particles. Multivariance analysis showed significant and positive correlation between HDL cholesterol/apoAI (HDL-C/apoAI) and HDL-C/HDL ratios, which indicates that both ratios could sensitively reflect changes in the HDL subclasses and their distribution into smaller size particles. In Tx patients, the decreased HDL-C/apoAI ratio indicates that, along with the decreased apoAI concentration, the HDL-C level is decreased. However, a low HDL-C/HDL ratio indicates that HDL particles in Tx patients transport lesser content of HDL-C but more triglyceride (TG) (high TG/HDL ratio), and thus are hypercatabolized and removed; therefore, concentration of HDL particles in serum was decreased.
CONCLUSION: The decrease of HDL-C/apoAI ratio seems to be a good marker of HDL subclass distribution into smaller size particles.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349521      PMCID: PMC2852541          DOI: 10.1631/jzus.B1000012

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  28 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Risk factors for and management of post-transplantation cardiovascular disease.

Authors:  B Fellström
Journal:  BioDrugs       Date:  2001       Impact factor: 5.807

3.  Relationship between apolipoprotein C-III concentrations and high-density lipoprotein subclass distribution.

Authors:  Li Tian; Jin Wu; Mingde Fu; Yanhua Xu; Lianqun Jia
Journal:  Metabolism       Date:  2009-05       Impact factor: 8.694

4.  Lipolytically modified triglyceride-enriched HDLs are rapidly cleared from the circulation.

Authors:  Shirya Rashid; P Hugh R Barrett; Kristine D Uffelman; Takehiko Watanabe; Khosrow Adeli; Gary F Lewis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection.

Authors:  K M Wissing; D Abramowicz; N Broeders; P Vereerstraeten
Journal:  Transplantation       Date:  2000-08-15       Impact factor: 4.939

7.  Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.

Authors:  E M Rubin; B Y Ishida; S M Clift; R M Krauss
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

8.  Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.

Authors:  E A Brinton; S Eisenberg; J L Breslow
Journal:  Arterioscler Thromb       Date:  1994-05

9.  Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study.

Authors:  J Contois; J R McNamara; C Lammi-Keefe; P W Wilson; T Massov; E J Schaefer
Journal:  Clin Chem       Date:  1996-04       Impact factor: 8.327

10.  Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative.

Authors:  B Kasiske; F G Cosio; J Beto; K Bolton; B M Chavers; R Grimm; A Levin; B Masri; R Parekh; C Wanner; D C Wheeler; P W F Wilson
Journal:  Am J Transplant       Date:  2004       Impact factor: 8.086

View more
  7 in total

Review 1.  Lipid abnormalities in kidney disease and management strategies.

Authors:  Vishwam Pandya; Akhilesh Rao; Kunal Chaudhary
Journal:  World J Nephrol       Date:  2015-02-06

2.  Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.

Authors:  Elżbieta Kimak; Magdalena Hałabiś; Iwona Baranowicz-Gąszczyk; Janusz Solski; Andrzej Książek
Journal:  J Zhejiang Univ Sci B       Date:  2011-05       Impact factor: 3.066

3.  A comparison of the theoretical relationship between HDL size and the ratio of HDL cholesterol to apolipoprotein A-I with experimental results from the Women's Health Study.

Authors:  Norman A Mazer; Franco Giulianini; Nina P Paynter; Paul Jordan; Samia Mora
Journal:  Clin Chem       Date:  2013-02-20       Impact factor: 8.327

4.  Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients.

Authors:  Ji Eun Kim; Mi-Yeon Yu; Yong Chul Kim; Sang-Il Min; Jongwon Ha; Jung Pyo Lee; Dong Ki Kim; Kook-Hwan Oh; Kwon-Wook Joo; Curie Ahn; Yon Su Kim; Hajeong Lee
Journal:  Clin Exp Nephrol       Date:  2019-08-29       Impact factor: 2.801

5.  Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoproteins, and LCAT and CETP activity in post-renal transplant patients.

Authors:  Elżbieta Kimak; Jerzy Bylina; Janusz Solski; Magdalena Hałabiś; Iwona Baranowicz-Gąszczyk; Andrzej Książek
Journal:  Cell Biochem Biophys       Date:  2013-11       Impact factor: 2.194

6.  Lipids and lipoproteins and inflammatory markers in patients with chronic apical periodontitis.

Authors:  Aleksandra Kimak; Małgorzata Strycharz-Dudziak; Teresa Bachanek; Elżbieta Kimak
Journal:  Lipids Health Dis       Date:  2015-12-14       Impact factor: 3.876

7.  Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease.

Authors:  Elżbieta Kimak; Bartosz Zięba; Dariusz Duma; Janusz Solski
Journal:  Lipids Health Dis       Date:  2018-04-04       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.